Summary of Product Characteristics
last updated on the eMC:
15/02/2011
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 15/02/2011 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 4.2 - Posology and method of administration
|
| Date of revision of text on the SPC: 08-Feb-2011 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| The amendment instructs the parent to give Gaviscon Infant half way through the feed rather than at the end of the feed. This has been made because we have found through the consumer feedback that breast fed infants are often not hungry at the end of the feed and parents find it difficult to get their infant to take the full dose of Gaviscon. Insufficient dosing could lead to a loss of effectiveness of the product.
|
|
Updated on 06/07/2009 and displayed until 15/02/2011
|
Reasons for adding or updating:
|
-
New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
|
| Date of revision of text on the SPC: |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| None provided |
|
